BVS Q3'26 Earnings Preview: EPS Estimate 0.15 USD
Bioventus is scheduled to report Q3'26 results on November 02 after the market closes. Revenue is estimated at 149.51 million USD; EPS is estimated at 0.15 USD.
Bioventus is scheduled to report Q3'26 results on November 02 after the market closes. Revenue is estimated at 149.51 million USD; EPS is estimated at 0.15 USD.